Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
Christian Drosten, Stephan Günther, Wolfgang Preiser, Sylvie van der Werf, H.-R. Brodt, Stephan Becker, Holger Felix Rabenau, Marcus Panning, Larissa Kolesnikova, Ron A. M. Fouchier, Annemarie Berger, Ana Maria Burguière, Jindrich Jr. Cinatl, Markus Eickmann, Nicolas Escriou, Klaus Grywna, Stefanie Kramme, Jean‐Claude Manuguerra, Stefanie Müller, Volker Rickerts, Martin Stürmer, Simon Vieth, Hans‐Dieter Klenk, Albert D. M. E. Osterhaus, HERBERT E. SCHMITZ, Hans Wilhelm Doerr
New England Journal of Medicine · 2003 · 4,631 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Drosten, C., Günther, S., Preiser, W., Werf, S. van der, Brodt, H.-R., Becker, S., Rabenau, H. F., Panning, M., Kolesnikova, L., Fouchier, R. A. M., Berger, A., Burguière, A. M., Cinatl, J. J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J., Müller, S., … Doerr, H. W. (2003). Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New England Journal of Medicine, 348(20), 1967–1976. https://doi.org/10.1056/nejmoa030747
In text: (Drosten et al., 2003)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
BACKGROUND: The severe acute respiratory syndrome (SARS) has recently been identified as a new clinical entity. SARS is thought to be caused by an unknown infectious agent. METHODS: Clinical specimens from patients with SARS were searched for unknown viruses with the use of cell cultures and molecular techniques. RESULTS: A novel coronavirus was identified in patients with SARS. The virus was isolated in cell culture, and a sequence 300 nucleotides in length was obtained by a polymerase-chain-reaction (PCR)-based random-amplification procedure. Genetic characterization indicated that the virus is only distantly related to known coronaviruses (identical in 50 to 60 percent of the nucleotide sequence). On the basis of the obtained sequence, conventional and real-time PCR assays for specific and sensitive detection of the novel virus were established. Virus was detected in a variety of clinical specimens from patients with SARS but not in controls. High concentrations of viral RNA of up to 100 million molecules per milliliter were found in sputum. Viral RNA was also detected at extremely low concentrations in plasma during the acute phase and in feces during the late convalescent phase. Infected patients showed seroconversion on the Vero cells in which the virus was isolated. CONCLUSIONS: The novel coronavirus might have a role in causing SARS.
Related papers
- Clinical Characteristics of Coronavirus Disease 2019 in China2020
- A Novel Coronavirus from Patients with Pneumonia in China, 20192020
- A pneumonia outbreak associated with a new coronavirus of probable bat origin2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China2020
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine2020
Metadata from OpenAlex (CC0). Citations are generated from the published record.